Press Releases

April 27, 2026

QScreen AI Completes Platform That Identifies Probable Drug a Person Has Consumed in Real Time from a Camera Alone – Targets Correctional Facilities Facing Coroner Scrutiny over Withdrawal Deaths

QScreen AI Inc. has completed development of its patent-protected QAI physiological AI clinical platform, capable of identifying probable drug classes—including alcohol, opioids, benzodiazepines, stimulants, and cannabis—using only a standard laptop camera in real time. The…

Read full release →

February 27, 2026

QScreen arranges $500,000 private placement

Dr. Rahul Kushwah reports QSCREEN AI ANNOUNCES STRATEGIC FINANCING TO ADVANCE COMMERCIALIZATION INITIATIVES ACROSS NORTH AMERICA QScreen AI Inc. has arranged a non-brokered private placement. The company intends to issue up to 10 million units…

Read full release →

February 17, 2026

QScreen AI files patent application in U.S.

Dr. Rahul Kushwa reports QSCREEN AI ADVANCES QUANTUM-INSPIRED OPTIMIZATION WITH U.S. PATENT FILING; GAINS NATIONAL SPOTLIGHT ON CBC QScreen AI Inc. has filed a provisional patent application with the U.S. Patent and Trademark Office. Entitled…

Read full release →

February 09, 2026

QSceen AI hires Global Frontier Advisors

Dr. Rahul Kushwah reports QSCREEN AI ANNOUNCES STRATEGIC U.S. ENGAGEMENT TO DRIVE INNOVATION IN PUBLIC SAFETY AND INSTITUTIONAL HEALTH QScreen AI Inc. has entered into an independent contractor agreement with Global Frontier Advisors LP (GFA),…

Read full release →